# Desmond Schatz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/desmond-schatz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,245 |
| Field | Diabetes and associated disorders |
| h-index | 92 |
| i10-index | 299 |
| Last Known Institution | University of Florida |
| OpenAlex ID | https://openalex.org/A5044863989 |
| ORCID iD | https://orcid.org/0000-0002-1044-5762 |
| Works | 542 |

## Researcher papers

- [Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range](https://scholariq.org/papers/clinical-targets-for-continuous-glucose-monitoring-data-interpretation/)
- [Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association](https://scholariq.org/papers/staging-presymptomatic-type-1-diabetes-a-scientific-statement-of-jdrf-the/)
- [An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes](https://scholariq.org/papers/an-anti-cd3-antibody-teplizumab-in-relatives-at-risk-for-type-1-diabetes/)
- [Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function](https://scholariq.org/papers/rituximab-b-lymphocyte-depletion-and-preservation-of-beta-cell-function/)
- [Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis](https://scholariq.org/papers/differentiation-of-diabetes-by-pathophysiology-natural-history-and-prognosis/)
- [Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/co-stimulation-modulation-with-abatacept-in-patients-with-recent-onset-type-1/)
- [Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice](https://scholariq.org/papers/consensus-recommendations-for-the-use-of-automated-insulin-delivery-technologies/)
- [Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes](https://scholariq.org/papers/insulin-dose-optimization-using-an-automated-artificial-intelligence-based/)
- [A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk](https://scholariq.org/papers/a-type-1-diabetes-genetic-risk-score-predicts-progression-of-islet-autoimmunity/)
- [A combined risk score enhances prediction of type 1 diabetes among susceptible children](https://scholariq.org/papers/a-combined-risk-score-enhances-prediction-of-type-1-diabetes-among-susceptible/)

## Researcher topics

- [Diabetes and associated disorders](https://scholariq.org/topics/diabetes-and-associated-disorders/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)

## Researcher university

- [University of Florida](https://scholariq.org/institutions/university-of-florida/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.